Optimer Pharmaceuticals, Inc. (OPTR)

[mlkrborn]

OPTR $17+ ; eurozone news: "Optimer Pharma and Astellas receive positive opinion from CHMP for European Approval of DIFICID (OPTR) 16.87 : OPTR announced that the Committee for Medicinal Products for Human Use of the European Medicines Agency has adopted a positive opinion for DIFICLIR tablets for the treatment of adults suffering with a Clostridium difficile infection. The CHMP positive opinion is based on Phase 3 clinical studies that were conducted to compare the safety and efficacy of 400mg/day fidaxomicin with 500mg/day oral vancomycin for 10 days in subjects with CDI."